Daunorubicin
ATC L01DB02 · 11 markets · 34 records
Daunorubicin
Forms
US 6 records · 2 strengths
- 5 mginjectionManufacturer: Hikma Pharmaceuticals USA I… ×2Manufacturer: Hisun Pharmaceuticals USA, …、Manufacturer: Meitheal Pharmaceuticals In…
- 44 mg/20 mLinjectionVYXEOS
CA 5 records · 3 strengths
- 5 mg/1 mLliquidDaunorubicin HydrochlorideDAUNORUBICIN INJECTABLE
- 44 mgpowderVYXEOS
- 20 mgpowderCERUBIDINE
AU 5 records · 3 strengths
- 20 mginjectionPFIZER DAUNORUBICIN daunorubicin (as hydrochloride) 18.7 mg powder for injection vial
- 44 mginjectionVYXEOS
Records without a stated strength · 1 daunorubicin、Pfizer Daunorubicin、VYXEOS
CN 5 records · 1 strengths
- 20 mginjectionManufacturer: 山东新时代药业有限公司 ×2Manufacturer: 深圳万乐药业有限公司、Manufacturer: 瀚晖制药有限公司
GB 3 records · 2 strengths
- 20 mginjectionManufacturer: A A H Pharmaceuticals LtdManufacturer: Zentiva Pharma UK Ltd
- 44 mginjectionVyxeos liposomal 44mg/100mg powder for concentrate for solution for infusion vials
ES 2 records · 2 strengths
- 20 mginjectionDAUNOBLASTINA
- 44 mginjectionVYXEOS LIPOSOMAL
SG 1 records · 1 strengths
- 20 mg/vialinjectionDAUNOCIN FOR INJECTION 20 mg/vial
MX 1 records · 1 strengths
Records without a stated strength · 1 DAKUP
TW 1 records · 1 strengths
- 20 mginjectionDAUNOBLASTINA 20MG FOR唐黴素注射劑
HK 1 records · 1 strengths
Records without a stated strength · 1 DAUNOBLASTINA FOR INJ 20MG
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 VYXEOS LIPOSOMAL
Easily confused with:盐酸多柔比星(Doxorubicin
DOXOrubicin) FDA recommends tall-man lettering for this pair; check the ingredient, not the name. All pairsThe same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.